Alignment Healthcare (NASDAQ:ALHC) Releases Quarterly Earnings Results, Beats Expectations By $0.10 EPS

Alignment Healthcare (NASDAQ:ALHC) posted its quarterly earnings data on Thursday. The company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.10, FiscalAI reports. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.The business had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1 billion.

Alignment Healthcare Stock Performance

Alignment Healthcare stock traded up $0.29 during mid-day trading on Thursday, reaching $20.42. The company’s stock had a trading volume of 2,602,844 shares, compared to its average volume of 2,716,924. The company has a market capitalization of $4.09 billion, a P/E ratio of -170.17, a PEG ratio of 4.99 and a beta of 1.16. The firm’s fifty day moving average price is $21.01 and its two-hundred day moving average price is $18.47. Alignment Healthcare has a 12-month low of $11.63 and a 12-month high of $23.87. The company has a debt-to-equity ratio of 1.99, a quick ratio of 1.61 and a current ratio of 1.61.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. TD Cowen raised their target price on Alignment Healthcare from $18.50 to $25.00 and gave the stock a “buy” rating in a research note on Friday, January 16th. Piper Sandler raised their target price on Alignment Healthcare from $20.00 to $30.00 and gave the company an “overweight” rating in a research note on Tuesday, January 6th. Wall Street Zen raised Alignment Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. UBS Group increased their target price on Alignment Healthcare from $18.00 to $21.00 and gave the stock a “neutral” rating in a report on Wednesday, January 14th. Finally, Robert W. Baird set a $28.00 price objective on shares of Alignment Healthcare in a research note on Friday, January 30th. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $23.95.

Insider Activity

In related news, insider Robert L. Scavo sold 69,541 shares of the company’s stock in a transaction that occurred on Monday, December 29th. The shares were sold at an average price of $18.74, for a total transaction of $1,303,198.34. Following the sale, the insider owned 503,014 shares of the company’s stock, valued at approximately $9,426,482.36. This represents a 12.15% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, President Dawn Christine Maroney sold 282,070 shares of Alignment Healthcare stock in a transaction dated Monday, December 29th. The shares were sold at an average price of $18.74, for a total value of $5,285,991.80. Following the sale, the president owned 1,385,167 shares of the company’s stock, valued at approximately $25,958,029.58. This trade represents a 16.92% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 2,125,938 shares of company stock worth $41,799,570. 7.00% of the stock is owned by company insiders.

Institutional Trading of Alignment Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. T. Rowe Price Investment Management Inc. grew its holdings in Alignment Healthcare by 0.6% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 12,643,784 shares of the company’s stock worth $249,715,000 after purchasing an additional 79,268 shares during the period. Invesco Ltd. boosted its stake in Alignment Healthcare by 38.9% in the 4th quarter. Invesco Ltd. now owns 6,202,592 shares of the company’s stock worth $122,501,000 after purchasing an additional 1,735,962 shares in the last quarter. Mercer Global Advisors Inc. ADV lifted its stake in shares of Alignment Healthcare by 6.9% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 15,452 shares of the company’s stock worth $305,000 after buying an additional 996 shares in the last quarter. Mackenzie Financial Corp increased its holdings in shares of Alignment Healthcare by 25.6% in the 4th quarter. Mackenzie Financial Corp now owns 46,917 shares of the company’s stock worth $901,000 after purchasing an additional 9,552 shares in the last quarter. Finally, nVerses Capital LLC bought a new stake in Alignment Healthcare in the 4th quarter worth about $396,000. Institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.